Current Iron Deficiency in CKD: Challenges/Controversies

ASN Satellite Symposium, sponsored by The University of Arizona College of Medicine at the Arizona Health Sciences Center. Philadelphia, PA, November, 2002.
Access to this program is free but HDCN free zone registration is required.
Introduction (precedes Dr. Aaronson's talk)
David Van Wyck, MD
Managing Anemia in CKD: Experience with High-Dose Iron Infusions
Michael Aaronson, MD

Hot Topics: Current Controversies in Iron Management
George Aronoff, MD

Safety Results of an Iron Sucrose Clinical Trial
Chaim Charytan, MD
Questions and Answers
Speakers and moderator

After participating in this activity, participants:

Will determine that, to assure safety, optimum IV iron therapy in the anemia of chronic kidney disease is guided by theoretical, laboratory and clinical assessment of potential adverse effects
Will recognize that rate of administration determines, in part, the total iron which can be safely administered in one dose.
Will consider that the total iron dose which can be administered in a single setting differs among IV iron agents including iron dextran, ferric gluconate, and iron sucrose.
Will summarize key findings in the US Clinical Trials of Iron Sucrose, and relate those findings to previous literature
Will consider that high ferritin levels, iron excess and iron deficiency are each associated with poor patient outcomes
Will realize that maintenance IV iron protocols more effectively prevent iron deficiency and that such protocols should aim to avoid ferritin levels above 800 ng/ml.
Michael Aaronson, MD
Assistant Clinical Professor of Medicine
North Central Kidney Institute
Avera Health
University of North Dakota Medical School
Sioux Falls, SD

George Aronoff, MD
Professor of Medicine and Pharmacology
Kidney Disease Program
University of Louisville School of Medicine
Louisville, Kentucky

Chaim Charytan, MD
Chief, Renal Division
NewYork Hospital Medical Center of Queens
Clinical Professor of Medicine
Cornell University College of Medicine
Flushing, NY

David Van Wyck, MD
Professor of Medicine and Surgery
The University of Arizona
College of Medicine
Tuscon, Arizona



CME

CE

Post-test and evaluation form are at this link, but you must listen to all talks from this symposium prior to completing the test.
CME: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint sponsorship of The University of Arizona College of Medicine at the Arizona Health Sciences Center and American Regent Laboratories, Inc. The University of Arizona College of Medicine at the Arizona Health Sciences Center is accredited by the ACCME to provide continuing medical education for physicians.

The University of Arizona College of Medicine at the Arizona Health Sciences Center designates this educational activity for a maximum of 1.5 hours in category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.

CE: These talks are also designated to provide 1.5 hours of CE Nursing Education credits, sponsored by the Renal Education Association. The Renal Education Association is accredited by the State of California Board of Nursing to provide continuing education for nurses (Provider number: CEP 13092).

Posting date: February, 2003.
Review date: February, 2004

INSTRUCTIONS FOR CREDIT :
Participation in this self-study activity should be completed in approximately two (1.5) hours. There are no fees for participating and receiving CME or CE credit for this activity. To successfully complete this activity and receive credit, participants must follow these steps during the period February, 2003 through February, 2004.
1. Register for continuing education credit by completing the registration process.
2. Read the goals and learning objectives.
3. Read the article text and tables, and review figures.
4. Read, complete, and submit answers to the post test questions and evaluation questions. You must receive a test score of at least 75% and respond to all evaluation questions to receive your online CME or CE certificate.

TARGET AUDIENCE :
The primary target audience is physicians involved in the care of renal patients (CME), and nephrology nurses, dietitians, dialysis technicians and pharmacists (CE).

FACULTY DISCLOSURE STATEMENTS :
All faculty participating in continuing medical education programs are expected to disclose to the program audience any real or apparent conflict of interest related to the subject under discussion. The faculty disclosure information is as follows:
Aaronson, Michael: received research funding, honoraria, or served on an advisory board for; American Regent, Amgen, Astra-Zeneca, Aventis, Boehringer-Ingelheim, Eli Lilly, Merch, Novartis, Ortho-Biotech, Parke-Davis, Pfizer, Pharmacia & Upjohn
Aronoff, George: received research funding, honoraria, or served on an advisory board for American Regent, Amgen, Astra-Zeneca, Aventis, Boehringer-Ingelheim, Eli Lilly, Merck, Novartis, Ortho Biotech, Clarke-Davis, Pfizer, Pharmacia-Upjohn, Schein, Solvay
Charytan, Chaim: received research funding, honoraria, or served on an advisory board for Amgen, Ortho, Am Regent, Ortho Biotech.
Van Wyck, David: is a member of the Speakers Bureau for American Regent Labs, Inc. and Amgen, Inc.

DISCLOSURE OF UNLABELED USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The University of Arizona, HDCN and the Renal Education Association do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

This educational activity is supported by an educational grant from American Regent, Inc.
This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies and with CE policies of the State of California Board of Registered Nursing.
Although not an official part of ASN's 2002 Renal Week Program, this meeting has been reviewed and its presentation permitted by the Society.
BACK TO
TOPIC INDEX :